Jonathan Weller

816 total citations
31 papers, 504 citations indexed

About

Jonathan Weller is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jonathan Weller has authored 31 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Jonathan Weller's work include Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (10 papers) and Meningioma and schwannoma management (6 papers). Jonathan Weller is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (10 papers) and Meningioma and schwannoma management (6 papers). Jonathan Weller collaborates with scholars based in Germany, Switzerland and United States. Jonathan Weller's co-authors include Alexander Schulte, Katrin Lamszus, Mareike Holz, Christel Herold‐Mende, Rainer Glaß, Niklas Thon, Alan Jackson, Michael Weller, Michael Müller and Guobin Bao and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Jonathan Weller

30 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Weller Germany 11 261 152 127 116 95 31 504
Aria Jamshidi United States 11 210 0.8× 120 0.8× 78 0.6× 65 0.6× 103 1.1× 44 524
Jethro Hu United States 13 295 1.1× 139 0.9× 85 0.7× 112 1.0× 33 0.3× 34 471
Marta Padovan Italy 13 282 1.1× 91 0.6× 79 0.6× 76 0.7× 38 0.4× 47 435
Mohammed G. Abdelwahab United States 11 208 0.8× 309 2.0× 60 0.5× 182 1.6× 154 1.6× 16 762
Ana Ortiz de Méndivil Spain 9 125 0.5× 261 1.7× 74 0.6× 211 1.8× 43 0.5× 14 459
Fadi Saadeh Lebanon 9 168 0.6× 177 1.2× 176 1.4× 104 0.9× 30 0.3× 13 475
Slávka Lukacova Denmark 12 215 0.8× 89 0.6× 133 1.0× 74 0.6× 22 0.2× 33 405
Xueling Qi China 12 206 0.8× 218 1.4× 88 0.7× 115 1.0× 38 0.4× 52 570
Thomas Olsson Bontell Sweden 11 257 1.0× 204 1.3× 78 0.6× 90 0.8× 27 0.3× 29 578
Sarah C. Jost United States 12 323 1.2× 158 1.0× 125 1.0× 48 0.4× 67 0.7× 15 770

Countries citing papers authored by Jonathan Weller

Since Specialization
Citations

This map shows the geographic impact of Jonathan Weller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Weller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Weller more than expected).

Fields of papers citing papers by Jonathan Weller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Weller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Weller. The network helps show where Jonathan Weller may publish in the future.

Co-authorship network of co-authors of Jonathan Weller

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Weller. A scholar is included among the top collaborators of Jonathan Weller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Weller. Jonathan Weller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trumm, Christoph, Patrick N. Harter, Louisa von Baumgarten, et al.. (2024). Determinants of long-term survival in patients with IDH-mutant gliomas. Journal of Neuro-Oncology. 170(3). 655–664. 2 indexed citations
2.
Weller, Jonathan, Marcus Unterrainer, Adrien Holzgreve, et al.. (2024). Patterns of intersectional tumor volumes in T2-weighted MRI and [18F]FET PET in adult glioma: a prospective, observational study. Scientific Reports. 14(1). 23071–23071. 1 indexed citations
3.
Weller, Jonathan, Alba Corell, Niloufar Javanmardi, et al.. (2024). The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase–Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3. Neurosurgery. 96(2). 365–372. 1 indexed citations
4.
Weller, Jonathan, et al.. (2024). Long-term outcome of surgically treated and conservatively managed Rathke cleft cysts. Acta Neurochirurgica. 166(1). 159–159.
5.
6.
Siller, Sebastian, et al.. (2023). Dorsal column mapping in resection of intramedullary spinal cord tumors: a prospective comparison of two methods and neurological follow-up. Acta Neurochirurgica. 165(11). 3493–3504. 2 indexed citations
7.
Terpolilli, Nicole A., et al.. (2023). Minimally invasive third ventriculostomy with stereotactic internal shunt placement for the treatment of tumor-associated noncommunicating hydrocephalus. Acta Neurochirurgica. 165(12). 4071–4079. 3 indexed citations
8.
Stahl, Robert, Melvin D’Anastasi, Robert Forbrig, et al.. (2023). Accuracy, Hemorrhagic Complications and CT Radiation Dose of Emergency External Ventricular Drain (EVD) Placement in Pediatric Patients: A 15-Year Retrospective Analysis. Diagnostics. 13(17). 2805–2805. 1 indexed citations
9.
Weller, Jonathan, Patrick N. Harter, Jochen Herms, et al.. (2023). Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status. Journal of Neuro-Oncology. 163(2). 407–415. 3 indexed citations
10.
Weller, Jonathan, Stefanie Quach, Rupert Egensperger, et al.. (2022). Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3. Journal of Neuro-Oncology. 160(1). 149–158. 5 indexed citations
11.
Weller, Jonathan, Mario M. Dorostkar, Nathalie L. Albert, et al.. (2022). Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas. Frontiers in Neurology. 13. 822362–822362. 25 indexed citations
12.
Karschnia, Philipp, Jonathan Weller, Veit M. Stoecklein, et al.. (2021). Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers. Scientific Reports. 11(1). 20045–20045. 2 indexed citations
13.
Teske, Nico, Philipp Karschnia, Jonathan Weller, et al.. (2021). Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?. Journal of Neuro-Oncology. 156(2). 317–327. 7 indexed citations
14.
Weller, Jonathan, Philipp Karschnia, Rupert Egensperger, et al.. (2021). PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression. Journal of Neuro-Oncology. 153(2). 283–291. 14 indexed citations
15.
Wirsching, Hans‐Georg, Ulrich Roelcke, Jonathan Weller, et al.. (2020). MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial. Clinical Cancer Research. 27(1). 179–188. 23 indexed citations
16.
Karschnia, Philipp, Nico Teske, Mario M. Dorostkar, et al.. (2020). Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II. Scientific Reports. 10(1). 19758–19758. 9 indexed citations
17.
Burkhardt, Jan‐Karl, Ethan A. Winkler, Jonathan Weller, & Michael T. Lawton. (2020). Early versus Delayed Microsurgical Clipping of Additional Unruptured Aneurysms in Patients with Aneurysmal Subarachnoid Hemorrhage. World Neurosurgery. 142. e233–e237. 2 indexed citations
18.
Widhalm, Georg, Jonathan Weller, Seunggu J. Han, et al.. (2019). The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas. Journal of neurosurgery. 133(1). 79–88. 60 indexed citations
19.
Gramatzki, Dorothee, Patrick Roth, Elisabeth J. Rushing, et al.. (2018). Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. Annals of Oncology. 29(6). 1431–1436. 74 indexed citations
20.
Jackson, Alan, et al.. (2000). Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome.. British Journal of Radiology. 73(868). 438–442. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aria Jamshidi Breakdown of academic impact, for papers by Jethro Hu Breakdown of academic impact, for papers by Marta Padovan Breakdown of academic impact, for papers by Mohammed G. Abdelwahab Breakdown of academic impact, for papers by Ana Ortiz de Méndivil Breakdown of academic impact, for papers by Fadi Saadeh Breakdown of academic impact, for papers by Slávka Lukacova Breakdown of academic impact, for papers by Xueling Qi Breakdown of academic impact, for papers by Thomas Olsson Bontell Breakdown of academic impact, for papers by Sarah C. Jost
Rankless by CCL
2026